GNOM Holdings Information

GNOM is an equity ETF with a total of 48 individual holdings. The top holdings are Avidity Biosciences stock at 6.86%, Alnylam Pharmaceuticals at 5.95%, CRISPR Therapeutics AG at 5.13%, Guardant Health at 4.67%, and Arrowhead Pharmaceuticals at 4.44%.

Total Holdings

Top 10 Percentage

45.62%

Asset Class

Equity

ETF Category

n/a

Assets

53.61M

PE Ratio

n/a

Sector Allocation

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	RNA	Avidity Biosciences, Inc.	6.86%	53,382
2	ALNY	Alnylam Pharmaceuticals, Inc.	5.95%	6,767
3	CRSP	CRISPR Therapeutics AG	5.13%	42,493
4	GH	Guardant Health, Inc.	4.67%	35,885
5	ARWR	Arrowhead Pharmaceuticals, Inc.	4.44%	61,240
6	ILMN	Illumina, Inc.	3.96%	21,476
7	NTRA	Natera, Inc.	3.89%	11,017
8	TECH	Bio-Techne Corporation	3.85%	32,641
9	PRAX	Praxis Precision Medicines, Inc.	3.44%	10,087
10	QGEN	Qiagen N.V.	3.44%	38,695
11	QURE	uniQure N.V.	3.31%	26,515
12	WGS	GeneDx Holdings Corp.	3.20%	13,350
13	MRNA	Moderna, Inc.	3.02%	61,698
14	RARE	Ultragenyx Pharmaceutical Inc.	2.84%	43,876
15	LEGN	Legend Biotech Corporation	2.82%	47,747
16	BNTX	BioNTech SE	2.78%	14,261
17	VCYT	Veracyte, Inc.	2.72%	41,225
18	VRTX	Vertex Pharmaceuticals Incorporated	2.56%	3,322
19	BMRN	BioMarin Pharmaceutical Inc.	2.56%	26,434
20	HKG: 1548	Genscript Biotech Corporation	2.29%	597,318
21	BEAM	Beam Therapeutics Inc.	2.26%	46,052
22	A	Agilent Technologies, Inc.	2.10%	7,793
23	TWST	Twist Bioscience Corporation	1.90%	30,226
24	LON: AZN	AstraZeneca PLC	1.83%	5,952
25	GILD	Gilead Sciences, Inc.	1.70%	7,689

Showing 25 of 48 holdings

Subscribe to see the full list

Activate Now

As of Oct 27, 2025